New class of inhibitors targeting selectively the autophagic pathway
The invention discloses two chemical compound families derived from tetrahydrotriazine or coumarin selectively targeting the autophagic pathway.
Further information: PDF
DKFZ (German Cancer Research Center, Deutsches Krebsforschungszentrum)
Phone: +49-6221-42 2955
Contact
Dr. Ruth Herzog
As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.
Media Contact
All latest news from the category: Technology Offerings
Newest articles
STRONG Program Cuts Anxiety Issues in Immigrant and Refugee Students
The first randomized control trial of the school-based intervention called Supporting Transition Resilience of Newcomer Groups (STRONG) shows significant reductions in depression, anxiety and behavior problems among refugee and immigrant…
Physical Function Impairments Linked to Hospital Readmission Among 50+ Adults
Researchers from The Ohio State University Wexner Medical Center and College of Medicine’s School of Health and Rehabilitation Sciences (HRS) recently published a study that found a link between impairments in physical function and…
Study Reveals Exercise Improves Brain Insulin, Helps Prevent Dementia
Study confirms positive effects of exercise on insulin signaling proteins from the brain A study led by scientists at Rutgers University-New Brunswick has shown that specialized cells involved in how…